Literature DB >> 10643940

Changes in mammographic breast density and concomitant changes in breast cancer risk.

C H van Gils1, J H Hendriks, R Holland, N Karssemeijer, J D Otten, H Straatman, A L Verbeek.   

Abstract

Among participants of the biennial Nijmegen breast cancer screening programme, we examined whether diminution of mammographic breast density lowered breast cancer risk. Post-menopausal breast cancer cases (n = 108), who had to have participated in all the five screening rounds prior to their diagnosis, were matched to 400 controls on year of birth and screening history. Controls had to be free of breast cancer at the time of the case's diagnosis. Changes in breast density were measured over a 10-year period, by a fully computerized method. Women in whom 5-25% or >25% of the breast was composed of fibro-glandular density showed a threefold increased 10-year risk compared to women with <5% density. In women with 5-25% density initially, we observed a trend of decreasing risk with diminishing density: when women with <5% density throughout the whole period formed the reference category, the odds ratio (OR) for those who decreased from 5-25% to <5% density was 1.9 [95% confidence interval (CI) = 0.6-6.1] in contrast to the OR of 5.7 (95% CI = 2.2-15.2) for those with persisting 5-25% density. In women who increased from 5-25% density to >25% density the OR was 6.9 (95% CI = 2.1-22.9). In women with >25% density initially, diminishing density was not clearly associated with lowering risk, which may be partly explained by the low number of women who decreased to <5% (n = 12). Due to the limited size of the study these results have to be interpreted with caution. Although the results are not conclusive, they could indicate a trend of decreasing risk with diminishing breast density. Should this effect be real, it may have great implications for the primary prevention of breast cancer or for the identification of high-risk groups who would benefit by more frequent screening. Therefore, large-scale, long-term follow-up studies on the effects of changes in breast density are needed.

Entities:  

Mesh:

Year:  1999        PMID: 10643940     DOI: 10.1097/00008469-199912000-00006

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  20 in total

1.  Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812).

Authors:  Katherine D Crew; Garnet L Anderson; Dawn L Hershman; Mary Beth Terry; Parisa Tehranifar; Danika L Lew; Monica Yee; Eric A Brown; Sebastien S Kairouz; Nafisa Kuwajerwala; Therese Bevers; John E Doster; Corrine Zarwan; Laura Kruper; Lori M Minasian; Leslie Ford; Banu Arun; Marian Neuhouser; Gary E Goodman; Powel H Brown
Journal:  Cancer Prev Res (Phila)       Date:  2019-05-28

2.  Mammographic Density Change and Risk of Breast Cancer.

Authors:  Shadi Azam; Mikael Eriksson; Arvid Sjölander; Roxanna Hellgren; Marike Gabrielson; Kamila Czene; Per Hall
Journal:  J Natl Cancer Inst       Date:  2020-04-01       Impact factor: 13.506

3.  Physical activity and change in mammographic density: the Study of Women's Health Across the Nation.

Authors:  Shannon M Conroy; Lesley M Butler; Danielle Harvey; Ellen B Gold; Barbara Sternfeld; Nina Oestreicher; Gail A Greendale; Laurel A Habel
Journal:  Am J Epidemiol       Date:  2010-03-30       Impact factor: 4.897

4.  Longitudinal Changes in Volumetric Breast Density in Healthy Women across the Menopausal Transition.

Authors:  Natalie J Engmann; Christopher Scott; Matthew R Jensen; Stacey J Winham; Lin Ma; Kathleen R Brandt; Amir Mahmoudzadeh; Dana H Whaley; Carrie B Hruska; Fang-Fang Wu; Aaron D Norman; Robert A Hiatt; John Heine; John Shepherd; V Shane Pankratz; Diana L Miglioretti; Karla Kerlikowske; Celine M Vachon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-11       Impact factor: 4.254

5.  Reproducibility of BI-RADS breast density measures among community radiologists: a prospective cohort study.

Authors:  Mary C Spayne; Charlotte C Gard; Joan Skelly; Diana L Miglioretti; Pamela M Vacek; Berta M Geller
Journal:  Breast J       Date:  2012-05-21       Impact factor: 2.431

6.  Progestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.

Authors:  Eunjung Lee; Sue A Ingles; David Van Den Berg; Wei Wang; Chris Lavallee; Mei-Hua Huang; Carolyn J Crandall; Frank Z Stanczyk; Gail A Greendale; Giske Ursin
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

7.  Localized fibroglandular tissue as a predictor of future tumor location within the breast.

Authors:  Snehal M Pinto Pereira; Valerie A McCormack; John H Hipwell; Carol Record; Louise S Wilkinson; Sue M Moss; David J Hawkes; Isabel dos-Santos-Silva
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-06-21       Impact factor: 4.254

8.  Relationship Between Breast Density and Selective Estrogen-Receptor Modulators, Aromatase Inhibitors, Physical Activity, and Diet: A Systematic Review.

Authors:  Ernest U Ekpo; Patrick C Brennan; Claudia Mello-Thoms; Mark F McEntee
Journal:  Integr Cancer Ther       Date:  2016-04-29       Impact factor: 3.279

9.  Various doses of soy isoflavones do not modify mammographic density in postmenopausal women.

Authors:  Gertraud Maskarinec; Martijn Verheus; Francene M Steinberg; Paula Amato; Margaret K Cramer; Richard D Lewis; Michael J Murray; Ronald L Young; William W Wong
Journal:  J Nutr       Date:  2009-03-25       Impact factor: 4.798

10.  Decreased TGFbeta signaling and increased COX2 expression in high risk women with increased mammographic breast density.

Authors:  Wei Tse Yang; Michael T Lewis; Kenneth Hess; Helen Wong; Anna Tsimelzon; Nese Karadag; Michelina Cairo; Caimaio Wei; Funda Meric-Bernstam; Powel Brown; Banu Arun; Gabriel N Hortobagyi; Aysegul Sahin; Jenny C Chang
Journal:  Breast Cancer Res Treat       Date:  2009-02-25       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.